Related Experiment Video

Updated: Aug 12, 2025

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
09:34

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis

Published on: August 16, 2021

1.9K

Optimizing the Threshold to Treat Children for Latent Tuberculosis Infection: A North-East England Experience

George James Porter1,2, Martin Whyte3, Elisabetta Ghimenton Walters2,4

  • 1Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.

The Pediatric Infectious Disease Journal
|February 2, 2023
PubMed

Insights

Updated guidelines significantly increased latent tuberculosis infection (LTBI) treatment in children in North East England. More children received treatment under new tuberculin skin test interpretation rules, highlighting a substantial impact.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Latent tuberculosis infection (LTBI) requires careful management in children.
  • Tuberculin skin test (TST) interpretation guidelines have been updated to improve LTBI detection.
  • Effective LTBI treatment in pediatric populations is crucial for preventing active disease.

Purpose of the Study:

  • To evaluate the effect of revised TST interpretation guidelines on LTBI treatment rates in children.
  • To assess the clinical impact of updated LTBI screening protocols in a specific region.
  • To analyze changes in treatment initiation following guideline implementation.

Main Methods:

  • Retrospective analysis of pediatric LTBI screening data.
  • Inclusion of 241 children screened between January 2011 and July 2018.
  • Comparison of treatment rates under previous versus updated TST interpretation guidelines.

Main Results:

  • A significant increase in LTBI treatment was observed post-guideline update (33.3% vs. 12.4%).
  • The updated guidelines led to a statistically significant rise in children treated for LTBI (P < 0.001).
  • The study demonstrates a marked shift in clinical practice regarding LTBI management in children.

Conclusions:

  • Updated TST interpretation guidelines substantially increased LTBI treatment rates in children.
  • The revised guidelines appear effective in identifying and treating more children with LTBI.
  • This highlights the importance of guideline adherence for pediatric tuberculosis control.

More Related Videos

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.1K
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis09:57

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

8.7K

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
224
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
186
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
406
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
292
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
297
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.3K